Chad Pettit, MBA

Chad Pettit, MBA, is the executive director of global value access and policy for Amgen’s Biosimilars Business Unit. He develops global market access launch strategy for Amgen’s portfolio of 10 biosimilar medicines and leads on biosimilar policy matters in a new and rapidly growing segment of the industry. With his global perspective, Pettit is recognized as an expert on biosimilar commercialization and market access for biosimilars and the policy measures required to facilitate cost savings to patients and the healthcare system.


New content coming soon, please check back later.